{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:14:01Z","timestamp":1774502041742,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,2,7]]},"abstract":"<jats:p>Anticoagulant-related nephropathy is a type of acute kidney injury caused by overcoagulation. We describe a case of an 84-year-old man with arterial hypertension, coronary heart disease and atrial fibrillation treated with acenocoumarol, who presented with haematoproteinuria and acute kidney injury during a phase of excessive anticoagulation. In addition to IgA nephropathy, renal biopsy also revealed acute tubular necrosis, red blood cell casts and positive iron staining in tubular cells. After this acute episode, renal function improved and proteinuria decreased below the nephrotic range.<\/jats:p>","DOI":"10.1136\/bcr-2016-218748","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T15:00:17Z","timestamp":1487602817000},"page":"bcr2016218748","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Anticoagulant-related nephropathy in a patient with IgA nephropathy"],"prefix":"10.1136","volume":"2017","author":[{"given":"M\u00e1rio","family":"G\u00f3is","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Nolasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: a review","volume":"16","author":"Harter","year":"2015","journal-title":"West J Emerg Med"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","article-title":"Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?","volume":"80","author":"Barcellona","year":"1998","journal-title":"Thromb Haemost"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jth.13229","article-title":"Anticoagulation-related nephropathy","volume":"14","author":"Wheeler","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq493"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft380"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.6","first-page":"298261","article-title":"Dabigatran-related nephropathy in a patient with undiagnosed IgA Nephropathy","volume":"2015","author":"Escoli","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.7","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft076"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.024"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12882-016-0228-4","article-title":"Warfarin related nephropathy: a case report and review of literature","volume":"17","author":"Ng","year":"2016","journal-title":"BMC Nephrol"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.44"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2009.00723.x"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.12","doi-asserted-by":"publisher","DOI":"10.1038\/35025229"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-365973"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.14","first-page":"446","article-title":"Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure","volume":"256","author":"Zager","year":"1989","journal-title":"Am J Physiol"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2007.00538.x"},{"key":"2025042705270574000_2017.feb20_1.bcr2016218748.16","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00689.2012"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-218748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T12:27:13Z","timestamp":1745756833000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-218748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":16,"alternative-id":["10.1136\/bcr-2016-218748"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-218748","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]}}}